APA

Chance J. P., Fejzic H., Hernandez O., Istvan E. S., Andaya A., Maslov N., Aispuro R., Crisanto T., Nguyen H., Vidal B., Serrano W., Kuwahara B., Pugne Andanado C., Goldberg D. E. & Mallari J. P. (20181227). Development of piperazine-based hydroxamic acid inhibitors against falcilysin, an essential malarial protease. : Bioorganic & medicinal chemistry letters.

Chicago

Chance Jeffrey P, Fejzic Hannah, Hernandez Obiel, Istvan Eva S, Andaya Armann, Maslov Nikolay, Aispuro Ruby, Crisanto Teodulo, Nguyen Huyen, Vidal Brian, Serrano Whitney, Kuwahara Bradley, Pugne Andanado Corey, Goldberg Daniel E and Mallari Jeremy P. 20181227. Development of piperazine-based hydroxamic acid inhibitors against falcilysin, an essential malarial protease. : Bioorganic & medicinal chemistry letters.

Harvard

Chance J. P., Fejzic H., Hernandez O., Istvan E. S., Andaya A., Maslov N., Aispuro R., Crisanto T., Nguyen H., Vidal B., Serrano W., Kuwahara B., Pugne Andanado C., Goldberg D. E. and Mallari J. P. (20181227). Development of piperazine-based hydroxamic acid inhibitors against falcilysin, an essential malarial protease. : Bioorganic & medicinal chemistry letters.

MLA

Chance Jeffrey P, Fejzic Hannah, Hernandez Obiel, Istvan Eva S, Andaya Armann, Maslov Nikolay, Aispuro Ruby, Crisanto Teodulo, Nguyen Huyen, Vidal Brian, Serrano Whitney, Kuwahara Bradley, Pugne Andanado Corey, Goldberg Daniel E and Mallari Jeremy P. Development of piperazine-based hydroxamic acid inhibitors against falcilysin, an essential malarial protease. : Bioorganic & medicinal chemistry letters. 20181227.